Documente Academic
Documente Profesional
Documente Cultură
Type of
Vasculature
Epidemiology
Pathology &
Pathogenesis
Clinical
Manifestation
Churg-Strauss Syndrome
PAN
(Polyarteritis nodosa)
Small & medium sized muscular
arteries
(renal & visceral arteries)
Mutlisystem necrotizing vasculitis
Inflammation of entire wall
Uncommon dse
th th
2 M : 1 F @ 4 -5 decade
classic PAN
Segmental & bifurcations &
branches of arteries
Polymorphonuclear
neutrophilic infiltrates in all
layers of vessel wall
Intimal proliferation &
degeneration of entire vessel
wall
Compromises lumen ->
thrombos formation -> infarct
Assoc. w/ Hairy Cell leukemia
MPA
(Microscopic Polyangitis)
Small vessels esp. capillaries &
venules
Necrotizing vasculitis w/ no or
few immune complexes
GN & pulmonary capillaritis
M>F w/ mean age of 57 yrs
Histologically similar to PAN w/
predilection for capillaries and
venules
Minimal immuglobin deposition
Classification Criteria:
Wt loss of >4kg since onset
Livedo reticularis
Testicular pain/tenderness
Myalgias, weakness, leg
tenderness
Mono/polyneuropathies
Development of HPN
Takayasus Artertis
(Aortic Arch Syndrome)
Cranial/Temporal arteritis
F>M @ >50 y/o
5 most common:
1. Kidney Inflammation (80%)
2. Wt Loss (>70%)
3. Skin Lesion (>60%)
4. Nerve Damage (60%)
5. Fever (55%)
Gradual onset
Constitional: fever, wt loss,
musculoskeletal pain
Hemoptysis alveolar damage
Mononeuritis multiplex wristdrop
GI & cutanteous vasculitis
Splinter Hemorrhage
Muscle wasting
Labratory
Wegners Granulomatosis
Churg-Strauss Syndrome
PAN
(Polyarteritis nodosa)
MPA
(Microscopic Polyangitis)
(+) c-ANCA
(antiproteinase-3)
(+) p-ANCA
(antimyeloperoxidase)
(-) ANCA
(+) p-ANCA
(antimyeloperoxidase)
Diagnosic
Basis
Management
& Prognosis
CXR: nodular
densities/granulomas
predominately on lung base
Tissue Biopsy:
Pulmo. wedge biopsy
(highest yield)
Renal biopsy showing pauciimmune GN
3 Major Patho. Findings:
1. Parencymal necrosis
2. Vasculitis
3. Granulomatous
inflammation w/ mixed
cellular infiltrates
Education, vocational counseling
Physiotherapy
Supportive therapy
Prednisone improves
symptoms not course
(1mg/kgBW/day) Prednisone
to hydrocortisone @ 1:5
Cyclophosphamide
(2mg/kgBW)
Azathioprine (2mg/kg)
Methothrexate (start @
7.5mg/wk to 20-25mg/wk)
Mycophenolate mofetil (1g
BID)
Rituximab - biologic therapy
Tissue Biopsy:
1. Eosinophilic infiltrates
2. Peri/extra vascular small
necrotizing granulomas
3. Nectrotizing vasculitis
4. Lung necrosis
High ESR
Leukocytosis w/ PMN dominance
Hypergammaglobinemia
(inverted A:G ratio)
Elevated BUN/Crea unrelated to
dehydration or obstruction
Elevated ESR
Leukocytosis
Anemia
Thrombocytosis
Medication:
Prednisone &
cyclophosphamide - same as
Wegners
Antivirals for HBV
Anti-HPN
(-) ANCA
Elevated ESR
Normocytic Hypochromic Anemia
Elevated Alk PO4
Elevated IgG
Creatine Kinase normal
High ESR
Mild Anemia
High immune globulin
Biopsy of tissue
Arteriography (contrast MRA):
showing corkscrew appearance
of affected artery & aneurismal
dilation of aorta
Medication:
Prednisone (40-60 mg/day or
1mg/kgBW) gradually
tapered to control symptom
Aspirin reduce ischemic
complications
Methotrexate reduce
steroid dose
Spontaneous remission
94% 5yr survival rate
o
Mortality 2 to:
CHF
CVA
Renal
Aneurysm rupture
Takayasus Artertis
(Aortic Arch Syndrome)
Medication:
Prednisone (40-60 mg/day)
for acute S/Sx
Methotrexate (up to 25mg)
for refractory cases
Surgical & angiographic approach